Balaji Medivision Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 01-01-2025
- Paid Up Capital ₹ 5.00 Cr
as on 01-01-2025
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.00 Cr
as on 01-01-2025
- Revenue 122.01%
(FY 2023)
- Profit 163.42%
(FY 2023)
- Ebitda 79.37%
(FY 2023)
- Net Worth 11.31%
(FY 2023)
- Total Assets 54.77%
(FY 2023)
About Balaji Medivision
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹8.00 Cr.
Sangramsinh Sharad, Amarnath Patil, Rajashri Patil, and Nine other members serve as directors at the Company.
- CIN/LLPIN
U24299PN2021PTC199510
- Company No.
199510
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Kolhapur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Balaji Medivision?
Board Members (12)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sangramsinh Sharad  | Director | 22-Nov-2022 | Current |
| Amarnath Patil | Director | 16-Mar-2021 | Current |
| Rajashri Patil | Director | 16-Mar-2021 | Current |
| Anil Mhapsekar | Director | 05-Jun-2021 | Current |
| Rajendra Kore | Director | 05-Jun-2021 | Current |
| Madhuri Patil | Director | 05-Jun-2021 | Current |
Financial Performance of Balaji Medivision.
Balaji Medivision Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 122.01% increase. The company also saw a substantial improvement in profitability, with a 163.42% increase in profit. The company's net worth Soared by an impressive increase of 11.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Balaji Medivision?
In 2023, Balaji Medivision had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Balaji Vetgen Private LimitedActive 3 years 21 daysSangramsinh Sharad, Amarnath Patil and 2 more are mutual person
- Preeminence Life Care Private LimitedActive 3 years 4 months
Amarnath Patil and Rajendra Kore are mutual person
- Mp Chemistwala Private LimitedActive 11 months 18 days
Amarnath Patil, Rajendra Kore and 1 more are mutual person
Charges (Loans)
₹8.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 8.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Aug 2023 | Others | ₹8.00 Cr | Open |
How Many Employees Work at Balaji Medivision?
Balaji Medivision has a workforce of 80 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Balaji Medivision, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Balaji Medivision's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
